Infectious RNA: human immunodeficiency virus (HIV) biology, therapeutic intervention, and the quest for a vaccine

Y van Heuvel, S Schatz, JF Rosengarten, J Stitz - Toxins, 2022 - mdpi.com
Different mechanisms mediate the toxicity of RNA. Genomic retroviral mRNA hijacks infected
host cell factors to enable virus replication. The viral genomic RNA of the human …

CRISPR-Cas system: from diagnostic tool to potential antiviral treatment

A Rajan, S Shrivastava, Janhawi, A Kumar… - Applied Microbiology …, 2022 - Springer
This mini review focuses on the diagnosis and treatment of virus diseases using Crisper-Cas
technology. The present paper describes various strategies involved in diagnosing diseases …

Progression of antiviral agents targeting viral polymerases

S Peng, H Wang, Z Wang, Q Wang - Molecules, 2022 - mdpi.com
Viral DNA and RNA polymerases are two kinds of very important enzymes that synthesize
the genetic materials of the virus itself, and they have become extremely favorable targets for …

Development of azaindole-based frameworks as potential antiviral agents and their future perspectives

Urvashi, JB Senthil Kumar, P Das… - Journal of Medicinal …, 2022 - ACS Publications
The azaindole (AI) framework continues to play a significant role in the design of new
antiviral agents. Modulating the position and isosteric replacement of the nitrogen atom of AI …

Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV

S Climaco-Arvizu, V Flores-López… - BMC Infectious …, 2022 - Springer
Abstract Introduction In Mexico, HIV genotyping is performed in people living with HIV
(PLWH) failing their first-line antiretroviral (ARV) regimen; it is not routinely done for all …

Dominant Negative Mutants of Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) Disrupt Core-Binding Factor Beta-Vif Interaction

S Duan, X Yu, C Wang, L Meng, Y Gai, Y Zhou… - Journal of …, 2022 - Am Soc Microbiol
Apolipoprotein B mRNA-editing catalytic polypeptide-like 3 family members (APOBEC3s)
are host restriction factors that inhibit viral replication. Viral infectivity factor (Vif), a human …

In vitro delivery of HIV-1 Nef-Vpr DNA construct using the human antimicrobial peptide LL-37

A Nikyar, A Bolhassani, F Rouhollah… - Current Drug …, 2022 - ingentaconnect.com
Background and Objectives: DNA-based therapeutic vaccines have been proposed as a
promising strategy for the treatment of established HIV infections. However, these vaccines …

Predicted cellular interactors of the endogenous retrovirus-K protease enzyme

S Narvey, A Vandenakker, M Rempel… - Frontiers in …, 2022 - frontiersin.org
Retroviral proteases are essential enzymes for viral replication and drive changes within the
cellular proteome. While several studies have demonstrated that protease (PR) enzymes …

[PDF][PDF] Bloquer la transcription du VIH pour verrouiller le virus

M Poirier, B Bonham, B Bell - Virologie, 2022 - pnmvh.org
La latence du virus de l'immunodéficience humaine (VIH) est actuellement un obstacle
majeur à l'éradication des cellules infectées. En effet, en état de latence, le VIH se réplique …

[HTML][HTML] Blocking HIV transcription to lockdown the virus

M Da Rocha, M Poirier, B Bonhamn, B Bell - Virologie, 2022 - jle.com
[1.] Montaner JSG, Lima VD, Harrigan PR, et al. Expansion of HAART coverage is
associated with sustained decreases in HIV/AIDS morbidity, mortality and hiv transmission …